Clinical Trials Directory

Trials / Completed

CompletedNCT02414581

Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7%

Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7% to Reduce the Rate Oral Colonization by Gram-negative Bacteria in Patients With Chemotherapy

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Hospital Regional de Alta Especialidad del Bajio · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Clinical triple-blind randomized controlled trial to assess the use of two different mouthwashes to reduce the oral colonization by gramnegative bacteria in patients with chemotherapy

Detailed description

Clinical triple-blind randomized controlled trial. With two arms to the study: 1. Mouth rinses with chlorhexidine-based solution at a concentration of 0.12%, using as a vehicle to 7% ethyl alcohol. 2. Mouthwashes with solution based only 7% ethyl alcohol. GOAL. Assess whether there decrease in the rate of oral colonization by gram-negative bacteria in patients with chemotherapy by using chlorhexidine mouthwash. SPECIFIC OBJECTIVES: 1. The rate of the oral colonization by gram-negative bacteria initiation of chemotherapy. 2. The rate of oral colonization by gram-negative bacteria after 10 days of initiation of chemotherapy. 3. Identify microbiologically gram-negative bacteria colonizing the oral cavity. SECONDARY OBJECTIVES 1\. The presence of severe neutropenia and fever in each study group during the first 10 days of starting treatment

Conditions

Interventions

TypeNameDescription
DRUGchlorhexidine 0.12%/Ethyl alcohol 7%Mouth rinses with chlorhexidine 0.12%-based solution
DRUGEthyl Alcohol 7%Mouth rinses with Ethyl Alcohol 7%-based solution
DRUGChlorhexidine 2%/Ethyl alcohol 7%Mouth rinses with chlorhexidine 2%-based solution

Timeline

Start date
2015-04-01
Primary completion
2016-08-01
Completion
2016-09-01
First posted
2015-04-10
Last updated
2018-05-25

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT02414581. Inclusion in this directory is not an endorsement.